Precision Prostate Consulting, LLC (PPC), a provider of AI-powered prostate cancer detection and diagnostic services, today announced the appointment of Jamie Richgels as Managing Partner. In this role, Richgels will lead the company’s strategic and technological growth initiatives while advancing PPC’s mission to expand access to high-quality prostate cancer diagnostics.

“We are thrilled to welcome Jamie to the PPC leadership team,” said Dr. Randall W. Jones, PhD., Managing Partner of Precision Prostate Consulting. “Jamie brings a strong combination of technical expertise, executive leadership, and AI strategy experience that aligns perfectly with where we are headed. His background in building secure, enterprise-grade platforms positions PPC well as we continue to expand our consumer-facing services.”

PPC’s service utilizes ProstatID™, North America’s first FDA-cleared prostate cancer screening, detection, and diagnostic AI software developed by Bot Image, Inc., to deliver AI-supported diagnostic reports within minutes of prostate MRI submission. ProstatID® achieved an area under the sensitivity-specificity curve (AUROC) of 93.6% as reported in its FDA clearance documentation.

Richgels brings more than two decades of technology and executive leadership experience, most recently as Partner, Board Member, and VP of Technology & Strategy at FileTrail, Inc., where he led the development and delivery of its global enterprise SaaS platform for records management and information governance. FileTrail served enterprise clients across legal, corporate, bio-pharma, energy, and government sectors and was acquired in 2024 by Litera, Inc.

Richgels holds a Master of Science in Computer Science from Georgia Tech with a focus on AI/ML and computational perception, and a Bachelor of Science in Computer Science and Business from the University of Minnesota. He also serves as Board Chairman of Capitol City Robotics, reflecting a long-standing commitment to AI advancement and STEM education.

“Prostate cancer remains one of the most significant health challenges facing men in the United States and Europe, yet access to advanced diagnostic tools remains out of reach for too many patients,” said Richgels. “Precision Prostate Consulting combines clinical expertise with FDA-cleared AI technology to improve diagnostic clarity and support informed decision-making. I’m honored to help lead the organization as we continue expanding access to high-quality prostate MRI interpretation for patients and their physicians.”

In his role as Managing Partner, Richgels will support PPC’s continued development of its secure, patient-focused platform and educational resources, simplifying the process for patients to upload their MRI and receive a detailed AI-generated diagnostic report within minutes.

About Precision Prostate Consulting, LLC

Precision Prostate Consulting provides patients and physicians with expert prostate MRI interpretation services utilizing ProstatID™, an advanced AI software platform developed by Bot Image, Inc. that is FDA-Cleared (US), CE-Marked (EU), and UKCA-Certified (UK), to deliver accurate, rapid, and accessible prostate cancer diagnostics for patients and providers alike. PPC is headquartered in Kennebunk, Maine. For more information, visit https://precisionprostateconsulting.com.

‍